Strategies to reduce use of antidepressants
T Kendrick - British Journal of Clinical Pharmacology, 2021 - Wiley Online Library
T Kendrick
British Journal of Clinical Pharmacology, 2021•Wiley Online LibraryAntidepressant prescribing has increased year on year since the introduction of the selective
serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are
now taking antidepressants for depression/anxiety, with a median length of treatment of
more than 2 years, but antidepressants can cause side effects and withdrawal symptoms
which increase with longer use. Surveys of antidepressant users suggest 30–50% have no
evidence‐based indication to continue, but coming off antidepressants is often difficult due …
serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are
now taking antidepressants for depression/anxiety, with a median length of treatment of
more than 2 years, but antidepressants can cause side effects and withdrawal symptoms
which increase with longer use. Surveys of antidepressant users suggest 30–50% have no
evidence‐based indication to continue, but coming off antidepressants is often difficult due …
Antidepressant prescribing has increased year on year since the introduction of the selective serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are now taking antidepressants for depression/anxiety, with a median length of treatment of more than 2 years, but antidepressants can cause side effects and withdrawal symptoms which increase with longer use. Surveys of antidepressant users suggest 30–50% have no evidence‐based indication to continue, but coming off antidepressants is often difficult due to fears of relapse, withdrawal symptoms and a lack of psychological treatments to replace maintenance treatment and prevent relapse. GPs should not prescribe antidepressants routinely for mild depressive/anxiety symptoms. Patients starting antidepressants should be advised that they are to be taken for a limited period only, and that there is a risk of withdrawal problems on stopping them. Prescribers should actively review long‐term antidepressant use and suggest coming off them slowly to patients who are well. The relationship between SSRI dose and serotonin transporter receptor occupancy suggests that hyperbolic tapering regimes may be helpful for patients with troubling withdrawal symptoms who cannot stop treatment within 4–8 weeks, and tapering strips can allow carefully titrated slower dose reduction over some months. Internet and telephone support to patients wanting to reduce their antidepressants is being trialled in the REDUCE programme. More research is needed to establish the incidence of withdrawal symptoms in representative samples of patients coming off antidepressants, and large randomised controlled trials are needed to test different tapering strategies.
Wiley Online Library
以上显示的是最相近的搜索结果。 查看全部搜索结果